Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 190.99-84.21-1.87172.3626.79

What is the latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM ?

The latest Core EBITDA Growth ratio of SAMRAT PHARMACHEM is 190.99 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025190.99
Mar2024-84.21
Mar2023-1.87
Mar2022172.36
Mar202126.79

How is Core EBITDA Growth of SAMRAT PHARMACHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 190.99
Positive
Mar2024 -84.21
Negative
Mar2023 -1.87
Negative
Mar2022 172.36
543.37
Mar2021 26.79 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare Core EBITDA Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹76.0 Cr 12.3% 10.5% -32.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

12.3%

10.5%

-32.9%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses